Although Andersen – its longstanding auditor – was reappointed at the meeting, a spokeswoman told AccountancyAge.com: ‘The company indicated [it would] review its auditor, but confirmed the reappointment because it is a publicly-listed company and is required to have auditors.’
She said the healthcare company, which also makes Marigold gloves, told shareholders that it was appropriate to focus on reviewing its audit arrangements following the agm.
Because the company’s results and the results of the investigation are so close to the agm, the company could not review its auditor situation prior to the meeting. However, sources close to the company say the process is already underway.
Chairman Stuart Wallis also told shareholders the investigation into overstated results, which included a £50m stock error, was ‘virtually complete’.
He said: ‘In relation to the previously announced investigation into the overstatement of results in prior periods, this investigation is now virtually complete and a file has been passed to the Serious Fraud Office for review.
‘Any further action in this matter will therefore be taken by the SFO.’
Andersen was unavailable to comment.
A new head of solutions, Aidan Brennan, has been appointed at KPMG UK
The second largest improvement in ‘significant’ levels of financial distress since the EU Referendum was in professional services, found research from Begbies Traynor
Just one half of UK practices have implemented a pricing structure around auto enrolment implementation and advice - with many suffering increased costs
Deloitte's north-west Europe foray; BDO, Smith & Williamson investment paths; Shelley Stock Hutter; and Wilkins Kennedy discussed by editor Kevin Reed on our Friday Afternoon Live broadcast